Assertio Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

[email protected] (Simply Wall St)
1 min read
0
In this article:

Assertio Holdings (NASDAQ:ASRT) Second Quarter 2024 Results

Key Financial Results

  • Revenue: US$31.1m (down 24% from 2Q 2023).

  • Net loss: US$3.67m (down by 143% from US$8.47m profit in 2Q 2023).

  • US$0.039 loss per share (down from US$0.15 profit in 2Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Assertio Holdings Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) missed analyst estimates by 25%.

Looking ahead, revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Pharmaceuticals industry in the US.

Performance of the American Pharmaceuticals industry.

The company's shares are down 21% from a week ago.

Risk Analysis

Be aware that Assertio Holdings is showing 3 warning signs in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement